King Wealth Management Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,379
| Closed | -$205K | – | 163 |
|
|
2024
Q4 | $205K | Buy |
+2,379
| New | +$205K | 0.03% | 148 |
|
|
2024
Q3 | – | Sell |
-14,784
| Closed | -$2.11M | – | 157 |
|
|
2024
Q2 | $2.11M | Sell |
14,784
-87
| -0.6% | -$12.4K | 0.35% | 40 |
|
|
2024
Q1 | $1.91M | Sell |
14,871
-3,671
| -20% | -$471K | 0.33% | 39 |
|
|
2023
Q4 | $1.92M | Buy |
18,542
+12,061
| +186% | +$1.25M | 0.37% | 40 |
|
|
2023
Q3 | $589K | Sell |
6,481
-10,035
| -61% | -$912K | 0.12% | 67 |
|
|
2023
Q2 | $1.34M | Buy |
16,516
+2
| +0% | +$162 | 0.27% | 46 |
|
|
2023
Q1 | $1.31M | Buy |
16,514
+200
| +1% | +$15.9K | 0.29% | 49 |
|
|
2022
Q4 | $1.1M | Sell |
16,314
-5,840
| -26% | -$395K | 0.26% | 53 |
|
|
2022
Q3 | $1.1M | Buy |
22,154
+6,060
| +38% | +$302K | 0.28% | 48 |
|
|
2022
Q2 | $897K | Buy |
16,094
+10,000
| +164% | +$557K | 0.21% | 60 |
|
|
2022
Q1 | $338K | Sell |
6,094
-4,112
| -40% | -$228K | 0.07% | 126 |
|
|
2021
Q4 | $572K | Hold |
10,206
| – | – | 0.11% | 96 |
|
|
2021
Q3 | $490K | Buy |
10,206
+4,002
| +65% | +$192K | 0.1% | 104 |
|
|
2021
Q2 | $260K | Hold |
6,204
| – | – | 0.05% | 149 |
|
|
2021
Q1 | $209K | Sell |
6,204
-6,000
| -49% | -$202K | 0.05% | 151 |
|
|
2020
Q4 | $426K | Sell |
12,204
-21,200
| -63% | -$740K | 0.1% | 104 |
|
|
2020
Q3 | $1.16M | Buy |
33,404
+20,002
| +149% | +$695K | 0.3% | 47 |
|
|
2020
Q2 | $439K | Buy |
13,402
+2
| +0% | +$66 | 0.13% | 91 |
|
|
2020
Q1 | $403K | Hold |
13,400
| – | – | 0.17% | 69 |
|
|
2019
Q4 | $388K | Buy |
+13,400
| New | +$388K | 0.1% | 91 |
|